middle.news
How Is Recce Pharmaceuticals Advancing Its Phase 3 Trial in Indonesia?
1:06am on Sunday 21st of December, 2025 AEDT
•
Healthcare
Read Story
How Is Recce Pharmaceuticals Advancing Its Phase 3 Trial in Indonesia?
1:06am on Sunday 21st of December, 2025 AEDT
Key Points
Phase 3 clinical trial underway with multiple Indonesian sites activated
R327 topical gel shows significant efficacy against antibiotic-resistant bacteria
Featured in WHO’s 2025 Global Antibacterial Pipeline Report
Cash balance of A$3.17 million with extended equity facility to 2031
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Recce Pharmaceuticals (ASX:RCE)
OPEN ARTICLE